New hope for painful skin condition: experimental drug CIT-013 enters Mid-Stage trial
NCT ID NCT06993233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new drug called CIT-013 can reduce symptoms of hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 96 adults with moderate to severe HS will receive either 50 mg, 100 mg, or a placebo every two weeks for 12 weeks. Researchers will check if the drug lowers disease activity and monitor for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CA-01
RECRUITINGBarrie, Canada
Contact
-
CA-02
RECRUITINGLondon, Canada
Contact
-
CA-03
RECRUITINGWinnipeg, Canada
Contact
-
CA-04
RECRUITINGNewmarket, Canada
Contact
-
CA-05
RECRUITINGCalgary, Canada
Contact
-
DE-01
RECRUITINGBochum, Germany
Contact
-
DE-02
RECRUITINGFrankfurt, Germany
Contact
-
DE-03
RECRUITINGOldenburg, Germany
Contact
-
DE-04
RECRUITINGDresden, Germany
Contact
-
DE-06
RECRUITINGBad Bentheim, Germany
Contact
-
DE-08
RECRUITINGKiel, Germany
Contact
-
ES-01
RECRUITINGValencia, Spain
Contact
-
ES-02
NOT_YET_RECRUITINGSantiago de Compostela, Spain
Contact
-
ES-03
NOT_YET_RECRUITINGSeville, Spain
Contact
-
ES-04
NOT_YET_RECRUITINGMadrid, Spain
Contact
-
ES-05
NOT_YET_RECRUITINGBarcelona, Spain
Contact
-
Erasmus UMC
RECRUITINGRotterdam, Netherlands
Contact
-
GB-02
RECRUITINGCardiff, United Kingdom
Contact
-
GB-04
RECRUITINGLondon, United Kingdom
Contact
-
GB-05
RECRUITINGChester, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PL-01
RECRUITINGRzeszów, Poland
Contact
-
PL-02
NOT_YET_RECRUITINGLodz, Poland
Contact
-
PL-03
RECRUITINGKatowice, Poland
Contact
-
PL-05
RECRUITINGWroclaw, Poland
Contact
-
PL-06
RECRUITINGBialystok, Poland
Contact
-
PL-08
RECRUITINGGdansk, Poland
Contact
-
PL-09
RECRUITINGPoznan, Poland
Contact
-
PL-10
RECRUITINGLodz, Poland
Contact